✦ LIBER ✦

Effect of topical rifamycin SV treatment on cyclosporin A blood levels in a renal transplant recipient

✍ Scribed by E. Renoult; J. Hubert; Ph. Trechot; D. Hestin; M. Kessler; J. L'Hermite

Publisher: Springer
Year: 1991
Tongue: English
Weight: 230 KB
Volume: 40
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00265860

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Blood-to-plasma distribution of cyclospo

Blood-to-plasma distribution of cyclosporin A in a renal transplant recipient

✍ N. Shibata; T. Minouchi; Y. Hayashi; H. Shibata; T. Ono; H. Shimakawa 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 124 KB

The effect of cyclosporin on lower limb

The effect of cyclosporin on lower limb blood flow in renal transplant recipients

✍ A. Davenport; A. Parkin 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 381 KB

Extrarenal effect of cyclosporine A on p

Extrarenal effect of cyclosporine A on potassium homeostasis in renal transplant recipients

✍ York Pei; Robert Richardson; Celia Greenwood; P. Y. Wong; Andrew Baines 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 117 KB

Effect of cyclosporine A on long-term al

Effect of cyclosporine A on long-term allograft function in pediatric renal transplant recipients

✍ A. W. Williams; B. Z. Morgenstern; Mary Murphy; D. S. Milliner 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 460 KB

The beneficial effects of oral nifedipin

The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients — a randomised prospective study

✍ Steven J. Harper; Jennifer Moorhouse; Keith Abrams; Adam Jurewicz; Michael Nicho 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 913 KB

Impact of long-term immunosuppression wi

Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients

✍ Thomas F. Schorn; Volker Kliem; Marina Bojanovski; Dubravka Bojanovski; Heinz Re 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 511 KB

To determine the impact of long-term immunosuppression on serum lipids in stable renal graft recipients we measured serum lipids and apolipoprotein B concentrations in 20 patients receiving therapy with cyclosporin (CsA) and low-dose prednisolone (CsA/P) and in 18 patients on therapy with azathiopri